207
Views
35
CrossRef citations to date
0
Altmetric
Review

Considering Fas ligand as a target for therapy

, , , &
Pages 119-134 | Published online: 22 Apr 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Articles from other publishers (33)

Keerthi Kurma, Andrea Boizard-Moracchini, Gael Galli, Mickael Jean, Pierre Vacher, Patrick Blanco & Patrick Legembre. (2021) Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188596.
Crossref
Shulamit B. Wallach-Dayan, Dmytro Petukhov, Ronit Ahdut-HaCohen, Mark Richter-Dayan & Raphael Breuer. (2021) sFasL—The Key to a Riddle: Immune Responses in Aging Lung and Disease. International Journal of Molecular Sciences 22:4, pages 2177.
Crossref
Heidi Schwarzenbach & Peter B. Gahan. (2021) Exosomes in Immune Regulation. Non-Coding RNA 7:1, pages 4.
Crossref
Alexia Belavgeni, Claudia Meyer, Julian Stumpf, Christian Hugo & Andreas Linkermann. (2020) Ferroptosis and Necroptosis in the Kidney. Cell Chemical Biology 27:4, pages 448-462.
Crossref
Michiro Muraki. (2020) Sensitization to cell death induced by soluble Fas ligand and agonistic antibodies with exogenous agents: A review. AIMS Medical Science 7:3, pages 122-203.
Crossref
Irina Korovina, Ales Neuwirth, David Sprott, Silvio Weber, Sheik Pran Babu Sardar Pasha, Bettina Gercken, Georg Breier, Ali El-Armouche, Andreas Deussen, Mike O. Karl, Ben Wielockx, Triantafyllos Chavakis & Anne Klotzsche-von Ameln. (2018) Hematopoietic hypoxia‐inducible factor 2α deficiency ameliorates pathological retinal neovascularization via modulation of endothelial cell apoptosis . The FASEB Journal 33:2, pages 1758-1770.
Crossref
Jianlin Qiao, Qi Luo, Na Liu, Guangyu Wei, Xiaoqing Wu, Jun Lu, Kai Tang, Yulu Wu, Jie Zi, Xiaoqian Li, Yun Liu, Wen Ju, Kunming Qi, Zhiling Yan, Zhenyu Li, Lingyu Zeng & Kailin Xu. (2018) Increased ADAM10 expression in patients with immune thrombocytopenia. International Immunopharmacology 55, pages 63-68.
Crossref
Michiro Muraki. (2018) Development of expression systems for the production of recombinant human Fas ligand extracellular domain derivatives using <em>Pichia pastoris</em> and preparation of the conjugates by site-specific chemical modifications: A review. AIMS Bioengineering 5:1, pages 39-62.
Crossref
Michiro Muraki. (2016) Preparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugation. SpringerPlus 5:1.
Crossref
Yohannes Haile, Katia Carmine-Simmen, Camille Olechowski, Bradley Kerr, R. Chris Bleackley & Fabrizio Giuliani. (2015) Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo. Journal of Neuroinflammation 12:1.
Crossref
Michiro Muraki. (2014) Improved production of recombinant human Fas ligand extracellular domain in Pichia pastoris: yield enhancement using disposable culture-bag and its application to site-specific chemical modifications. BMC Biotechnology 14:1.
Crossref
Adam J. Caulfield & Wyndham W. Lathem. (2014) Disruption of Fas-Fas Ligand Signaling, Apoptosis, and Innate Immunity by Bacterial Pathogens. PLoS Pathogens 10:8, pages e1004252.
Crossref
Henriette Ebsen, Marcus Lettau, Dieter Kabelitz & Ottmar Janssen. (2014) Identification of SH3 Domain Proteins Interacting with the Cytoplasmic Tail of the A Disintegrin and Metalloprotease 10 (ADAM10). PLoS ONE 9:7, pages e102899.
Crossref
Adam J. Caulfield, Margaret E. Walker, Lindsay M. Gielda & Wyndham W. Lathem. (2014) The Pla Protease of Yersinia pestis Degrades Fas Ligand to Manipulate Host Cell Death and Inflammation. Cell Host & Microbe 15:4, pages 424-434.
Crossref
Marcus Lettau, Matthias Voss, Henriette Ebsen, Dieter Kabelitz & Ottmar Janssen. (2014) Differential protein–protein interactions of full length human FasL and FasL fragments generated by proteolysis. Experimental Cell Research 320:2, pages 290-301.
Crossref
Feiyan Yang, Wei Cai, Kai Yang & Manhua Chen. (2012) PKCδ knockdown inhibits free fatty acid induction of endothelial cell apoptosis. Cell Biochemistry and Function 31:5, pages 380-384.
Crossref
Andreas Linkermann, Jan H. Bräsen, Nina Himmerkus, Shuya Liu, Tobias B. Huber, Ulrich Kunzendorf & Stefan Krautwald. (2012) Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney International 81:8, pages 751-761.
Crossref
Marcus Lettau, Maren Paulsen, Hendrik Schmidt & Ottmar Janssen. (2011) Insights into the molecular regulation of FasL (CD178) biology. European Journal of Cell Biology 90:6-7, pages 456-466.
Crossref
Konstantinos Argiris, Chrysoula Panethymitaki & Mahvash Tavassoli. (2011) Naturally occurring, tumor-specific, therapeutic proteins. Experimental Biology and Medicine 236:5, pages 524-536.
Crossref
David E. Joyner, Kevin B. Jones, Stephen L. Lessnick, Joshua D. Schiffman & R. Lor Randall. (2011) Potential for Modulation of the Fas Apoptotic Pathway by Epidermal Growth Factor in Sarcomas. Sarcoma 2011, pages 1-15.
Crossref
Andreas Linkermann, Nina Himmerkus, Lars Rölver, Kirsten A. Keyser, Philip Steen, Jan-Hinrich Bräsen, Markus Bleich, Ulrich Kunzendorf & Stefan Krautwald. (2011) Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney International 79:2, pages 169-178.
Crossref
M. Paulsen, B. Mathew, J. Qian, M. Lettau, D. Kabelitz & O. Janssen. (2009) FasL cross-linking inhibits activation of human peripheral T cells. International Immunology 21:5, pages 587-598.
Crossref
Esther Tamayo, Jorge Postigo, Giuseppe Del Giudice, Rino Rappuoli, Adalberto Benito, Hideo Yagita, Ramón Merino & Jesús Merino. (2009) Involvement of the intrinsic and extrinsic cell‐death pathways in the induction of apoptosis of mature lymphocytes by the Escherichia coli heat‐labile enterotoxin . European Journal of Immunology 39:2, pages 439-446.
Crossref
M. Lettau, M. Paulsen, D. Kabelitz & O. Janssen. 2009. Death Receptors and Cognate Ligands in Cancer. Death Receptors and Cognate Ligands in Cancer 49 61 .
Matthias Voss, Marcus Lettau, Maren Paulsen & Ottmar Janssen. (2008) Posttranslational regulation of Fas ligand function. Cell Communication and Signaling 6:1.
Crossref
J V Forrester, H Xu, T Lambe & R Cornall. (2008) Immune privilege or privileged immunity?. Mucosal Immunology 1:5, pages 372-381.
Crossref
Michiro Muraki. (2008) Improved secretion of human Fas ligand extracellular domain by N-terminal part truncation in Pichia pastoris and preparation of the N-linked carbohydrate chain trimmed derivative. Protein Expression and Purification 60:2, pages 205-213.
Crossref
O. Brenes, F. Arce, O. Gätjens-Boniche & C. Díaz. (2007) Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Biomedicine & Pharmacotherapy 61:6, pages 347-355.
Crossref
M Schulte, K Reiss, M Lettau, T Maretzky, A Ludwig, D Hartmann, B de Strooper, O Janssen & P Saftig. (2007) ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death & Differentiation 14:5, pages 1040-1049.
Crossref
Ying Hu, Stefan Rahlfs, Volker Mersch-Sundermann & Katja Becker. (2007) Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells. Biological Chemistry 388:2.
Crossref
Angela D. Janke, Fabrizio Giuliani & V. Wee Yong. (2006) IVIg attenuates T cell-mediated killing of human neurons. Journal of Neuroimmunology 177:1-2, pages 181-188.
Crossref
Marcus Lettau, Jing Qian, Andreas Linkermann, Mathieu Latreille, Louise Larose, Dieter Kabelitz & Ottmar Janssen. (2006) The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proceedings of the National Academy of Sciences 103:15, pages 5911-5916.
Crossref
Jing Qian, Marcus Lettau, Graziella Podda & Ottmar Janssen. (2005) FasL associated factors and their potential role in the regulation of FasL expression. Signal Transduction 5:4, pages 195-201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.